HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maja T Tomicic Selected Research

Maja T Tomicic Research Topics

Disease

16Neoplasms (Cancer)
07/2021 - 05/2002
12Glioma (Gliomas)
07/2021 - 01/2010
10Glioblastoma (Glioblastoma Multiforme)
05/2022 - 10/2011
4Colorectal Neoplasms (Colorectal Cancer)
04/2021 - 01/2018
3Melanoma (Melanoma, Malignant)
12/2018 - 08/2013
2Chromosome Aberrations (Chromosome Abnormalities)
07/2021 - 08/2002
1Ovarian Neoplasms (Ovarian Cancer)
09/2023
1Chromosomal Instability (Chromosome Stability)
07/2021
1Triple Negative Breast Neoplasms
12/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Breast Neoplasms (Breast Cancer)
10/2014
1Poisoning
01/2013
1Testicular Neoplasms (Testicular Cancer)
12/2010
1Hypersensitivity (Allergy)
11/2003
1Chromosome Breakage
08/2002
1Necrosis
08/2002
1Genomic Instability
05/2002

Drug/Important Bio-Agent (IBA)

7Temozolomide (Temodar)FDA LinkGeneric
07/2021 - 10/2015
7DNA (Deoxyribonucleic Acid)IBA
01/2019 - 05/2002
6SurvivinIBA
07/2021 - 01/2010
5Small Interfering RNA (siRNA)IBA
12/2018 - 07/2012
4Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 01/2013
4Proteins (Proteins, Gene)FDA Link
08/2013 - 10/2011
31,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
07/2021 - 10/2011
3Topotecan (Hycamtin)FDA LinkGeneric
01/2013 - 10/2005
2Cytostatic AgentsIBA
04/2021 - 01/2019
2IntegrinsIBA
12/2018 - 04/2017
2EnzymesIBA
01/2018 - 01/2013
2Transcription Factors (Transcription Factor)IBA
01/2017 - 10/2015
2NimustineIBA
10/2015 - 07/2012
2Messenger RNA (mRNA)IBA
08/2013 - 07/2012
2Topoisomerase I InhibitorsIBA
01/2013 - 01/2010
2Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2013 - 12/2008
1PlatinumIBA
09/2023
1TubulinIBA
09/2023
1taxaneIBA
09/2023
1Carboplatin (JM8)FDA LinkGeneric
09/2023
1SenotherapeuticsIBA
07/2021
1venetoclaxIBA
07/2021
1O-(6)-methylguanineIBA
07/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2021
1Vincristine (Oncovin)FDA LinkGeneric
12/2018
1CilengitideIBA
12/2018
1Paclitaxel (Taxol)FDA LinkGeneric
12/2018
1PoisonsIBA
12/2018
1MethyltransferasesIBA
01/2018
1GlucocorticoidsIBA
01/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2018
1ran GTP-Binding ProteinIBA
01/2018
1Caspase 3 (Caspase-3)IBA
04/2017
1Indicators and Reagents (Reagents)IBA
02/2017
1Histone Deacetylases (Histone Deacetylase)IBA
01/2017
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
12/2016
1Bcl-2-Like Protein 11IBA
10/2015
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
10/2015
1Caspase 9IBA
10/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2015
1mafosfamideIBA
10/2014
1fotemustine (Muphoran)IBA
10/2014
1Lomustine (CCNU)FDA Link
10/2014
1exodeoxyribonuclease IIBA
08/2013
1Exonucleases (3' 5' Exonuclease)IBA
08/2013
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2013
1CamptothecinIBA
01/2013
1AlkaloidsIBA
01/2013
1Oncogene Proteins (Oncogene Protein)IBA
05/2011
1Cisplatin (Platino)FDA LinkGeneric
12/2010
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2010
1Topoisomerase II InhibitorsIBA
12/2008
1trioctyl phosphine oxide (TOPO)IBA
10/2005
1NucleosidesIBA
08/2002
1Ganciclovir (Cytovene)FDA LinkGeneric
08/2002
1Acyclovir (Aciclovir)FDA LinkGeneric
08/2002
1penciclovir (Denavir)FDA Link
08/2002
1Purine NucleosidesIBA
08/2002
1Thymidine KinaseIBA
08/2002

Therapy/Procedure

14Therapeutics
07/2021 - 10/2005
1Drug Therapy (Chemotherapy)
09/2023
1Chemoradiotherapy
05/2022
1Ligation
01/2013